Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells.
Amélie FouquéOlivier DelalandeMickael JeanRémy CastellanoEmmanuelle JosselinMarine MalleterKenji F ShojiMac Dinh HungHariniaina RampanarivoYves CollettePierre van de WeghePatrick LegembrePublished in: Journal of medicinal chemistry (2019)
Keyphrases